US Stock MarketDetailed Quotes

AMPH Amphastar Pharmaceuticals

Watchlist
  • 41.110
  • +0.280+0.69%
Close Apr 26 16:00 ET
2.01BMarket Cap15.81P/E (TTM)

Amphastar Pharmaceuticals Key Stats

Amphastar Pharmaceuticals Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

Feb 28, 2024

Revenue(YoY)

178.11M

+31.91%
EPS(YoY)

0.68

+3.03%

Buy

Apr 28, 2024

Amphastar Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 181.081M--
--2024/Q1-- / 175.047M--
Feb 28, 20242023/Q4178.105M / 173.326M--
Nov 8, 20232023/Q3180.556M / 173.800M--
Aug 8, 20232023/Q2145.712M / 136.967M--
May 9, 20232023/Q1140.022M / 135.625M--
Feb 28, 20232022/Q4135.023M / 126.741M--
Nov 7, 20222022/Q3120.129M / 126.400M--
Aug 8, 20222022/Q2123.467M / 117.875M--
May 9, 20222022/Q1120.368M / 112.773M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 181.081M--
--2024/Q1-- / 175.047M--
Feb 28, 20242023/Q4178.105M / 173.326M--
Nov 8, 20232023/Q3180.556M / 173.800M--
Aug 8, 20232023/Q2145.712M / 136.967M--
May 9, 20232023/Q1140.022M / 135.625M--
Feb 28, 20232022/Q4135.023M / 126.741M--
Nov 7, 20222022/Q3120.129M / 126.400M--
Aug 8, 20222022/Q2123.467M / 117.875M--
May 9, 20222022/Q1120.368M / 112.773M--

Unlock Free Earnings Estimates

Amphastar Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 28, 2024

Buy

  • Buy

    66.67%
  • Hold

    33.33%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg